US4489097A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Intravenous solutions with antimicrobial agent
Assignee: Procter and Gamble Co
•
Filing: 1982-07-08
•
Granted: 1984-12-18
•
Expires: 2002-07-08
Abstract
Abstract Antifungal/antibacterial materials are added to sterile compositions intended for administration to humans or lower animals to minimize bacterial and mycotic contamination which can cause infections associated with the medical and veterinary use of such compositions.
Inventors
- 👤 Roger L. Stone
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-11-02 00:36
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/70; A61K31/7004; A61K31/185; A61K31/19; A61K38/00; A61K38/01; A61K47/00; A61K47/06; A61K47/26; A61K9/00; A61K9/0012; A61K9/0019
Claims Analysis
Total Claims: 3
Claim 1
Independent Claim
83 words
In a process for the administration of a nutritive or saline solution or dispersion intravenously to a human or lower animal, the improvement which comprises admixing therewith at pH 3.5 to 6.0 a safe and effective amount of n-hexanoic acid, n-octanoic acid or a pharmaceutically-acceptable, water-soluble salt thereof, prior to or concurrently with said administration, whereby substantially all microorganisms known to be associated with infusion-related septicemia are killed within 1 minute of contact a decreased incidence of mycotic and bacterial infection is secured.
Claim 2
Dependent Claim
83 words
In a process for the administration of a nutritive or saline solution or dispersion intravenously to a human or lower animal, the improvement which comprises admixing therewith at pH 3.5 to 6.0 a safe and effective amount of n-hexanoic acid, n-octanoic acid or a pharmaceutically-acceptable, water-soluble salt thereof, prior to or concurrently with said administration, whereby substantially all microorganisms known to be associated with infusion-related septicemia are killed within 1 minute of contact a decreased incidence of mycotic and bacterial infection is secured.
Claim 3
Dependent Claim
44 words
The process of claim 1 wherein the nutritive or saline solution or dispersion is admixed with n-octanoic acid or a pharmaceutically-acceptable, water-soluble salt thereof in an amount such that the solution or dispersion contains at least about a 3 millimolar, concentration of n-octanoic acid.
References Cited (Backward Citations)
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1987-12-18 | 1988-06-18 | 1988-12-18 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1991-12-18 | 1992-06-18 | 1992-12-18 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1995-12-18 | 1996-06-18 | 1996-12-18 | $7700.00 | Window Closed / Lapsed |